MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Lipocine Inc. (NASDAQ: LPCN)*
Organization & Developments: Lipocine
Parents
Lipocine Inc. (NASDAQ: LPCN)*
Children
2018: FDA panel shoots down Lipocine low-testosterone drug
2021: Lipocine Is One To Watch Based On Possible FDA Approval Of TLANDO And NASH Data
Jumps
Finance & Acquisitions: Lipocine
Key People: Lipocine